FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects

Summary

The purpose of this study is to address an Food Drug and Administration (FDA) request to provide safety data in pre-asthmatic patients, ages 6 months to \<12 months, following administration of fluticasone propionate HFA.

Timeline

Start

2006-08-30

Primary completion

2007-04-12

Completion

2007-04-12

Drugs

Indications